Tecnoss

What Tecnoss does

Tecnoss S.r.l. is an Italian medical device manufacturer founded in 1998 by Dr. Giuseppe Oliva, specializing in xenogenic biomaterials for bone and soft tissue regeneration. The company is headquartered in Giaveno (Province of Turin), Italy, with a registered office in Turin, and operates a single manufacturing facility producing approximately 300,000 units per year. Its core technology is a patented tissue conditioning and deantigenation process, originally developed by the founder in 1995, which preserves the natural collagen matrix of xenogenic (cross-species) tissue while achieving biocompatibility — the basis for a portfolio of CE-certified medical devices spanning bone substitutes, collagen membranes, dermal matrices, bone pastes, and ready-to-use gel formulations.

The product portfolio is commercialized under two sub-brands: OsteoBiol® (since 2001) dedicated to dental and oral surgery applications, and Tecnoss® (since 2009) serving the hospital and broader regenerative surgery market. Key products include Gen-Os® (Dual-Phase mineral/collagen bone matrix), Putty and MU bone pastes, mp3® (prehydrated ready-to-use biomaterial), Evolution and Special membranes, TSV-Gel (thermosensitive viscosity gel), GTO® (premium-grade biomaterial), and dermal matrices including Tecnoss® Protexa® and Graftygen® Derma. The entire portfolio holds CE 0477 medical device certification (obtained April 2019), succeeding the prior CE 0373 marks granted progressively from March 2000 onward.

Tecnoss generates revenue through one-time sales of medical device biomaterials to dental surgeons, oral surgeons, and hospital surgical departments via a two-step distribution model: products flow through qualified distribution partners in 70 countries worldwide, supported by clinical evidence (231 international publications) and a professional education platform (Bone Biomaterials & Beyond Academy). The company is privately held and founder-controlled, with a registered share capital of €40,000 and 11-50 employees; no external institutional investors, funding rounds, or M&A activity are disclosed. Over 1 million surgical interventions have been documented using OsteoBiol® biomaterials, providing a long clinical track record that underpins the company's brand and regulatory positioning.

Name

Tecnoss

Legal name

Tecnoss S.r.l.

Website

https://tecnoss.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

11–50 employees

Short description

Tecnoss S.r.l. is an Italian medical device manufacturer that designs and produces patented xenogenic collagenated biomaterials for bone and soft tissue regeneration, sold under the OsteoBiol® (dental) and Tecnoss® (hospital) brands through a 70-country distribution network.

Ownership category

akta.pro rank

Product category

Dental and Orthopedic Biomaterials

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM) (HLAHAEAG)

akta.pro secondary industries

Tissue-Engineered Constructs & Scaffolds (natural/synthetic biomaterials) (HLAAAGAB), Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts) (HLAHALAE), Wound Healing & Skin Regeneration (advanced dressings, skin substitutes) (HLAAAGAG)

Keywords

• Xenogenic bone grafts
• Dental regeneration materials
• Collagen matrices
• Guided tissue regeneration
• Bone substitute devices

Headquarters

HQ city

Giaveno

HQ country

Italy

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Biomaterial Medical Devices Sales: Tecnoss designs and produces xenogenic biomaterials sold as medical devices under Tecnoss® and OsteoBiol® brands. Revenue is generated through product sales to dental and surgical professionals via international distribution networks.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Tecnoss designs, produces, and documents xenogenic biomaterials used as medical devices for bone and soft tissue regeneration. Its portfolio, marketed under the OsteoBiol® (dental) and Tecnoss® (hospital) brands, includes bone substitutes, collagen membranes, dermal matrices, bone pastes, and prehydrated ready-to-use biomaterials manufactured at its facility in Giaveno, Turin, Italy. The products are built on a patented tissue conditioning and deantigenation process that preserves the natural collagen matrix while achieving cross-species biocompatibility.

Product overview

Tecnoss is a medical device company that designs and produces xenogenic biomaterials through its patented tissue conditioning and deantigenation technology. The company operates primarily through two sub-brands: OsteoBiol® (dedicated to dentistry) and Tecnoss® (targeting the hospital medical market). The product portfolio includes bone substitutes, collagen membranes, dermal matrices, and ready-to-use paste formulations. Key products include Gen-Os® (Dual-Phase bone matrix), Putty and MU bone pastes, mp3® (prehydrated biomaterial), TSV-Gel (thermosensitive gel), GTO® (premium biomaterial), and various membrane products (Special, Evolution, Duo-Teck, Button). All products are CE-marked medical devices manufactured at the company's facility in Giaveno, Turin, Italy, producing approximately 300,000 units annually with distribution to over 70 countries.

Differentiator

Problem solved

Functional benefit

Brands

• OsteoBiol: Biomaterials brand dedicated to dentistry. Produces xenogenic biomaterials for bone regeneration, including bone substitutes, membranes, collagen felt, bone paste, and other regenerative products. OsteoBiol products are distributed in over 70 countries worldwide.

Products and services

• Gen-Os® Dual-Phase bone matrix combining mineral and collagen phases, designed to mimic autologous bone for effective bone regeneration in dental and surgical applications.
• Putty Bone Paste Pre-formed bone paste biomaterial for easy application in bone regeneration procedures, providing ready-to-use handling for surgeons.
• MU Bone Paste Bone paste biomaterial designed for bone grafting applications, offering handling characteristics suited to surgical procedures.
• Special Membrane Resorbable collagen membrane for guided tissue and bone regeneration, providing a biological barrier function over bone grafting procedures.
• Evolution Membrane Advanced biological barrier membrane for grafting materials, positioned as the state of the art in membranes for regenerative procedures.
• Duo-Teck Collagen Felt Collagen felt product combining innovation with simplicity for tissue regeneration applications.
• Button Collagen Felt Collagen felt product designed for specific regeneration applications with enhanced handling characteristics.
• mp3® Prehydrated, collagenated ready-to-use biomaterial that simplifies surgical procedures and reduces preparation time at the chairside.
• Graftygen® Derma Dermal regeneration product for soft tissue repair applications in medical procedures.
• Tecnoss® Protexa® Dermal matrix product establishing a new standard for dermal regeneration applications in hospital/medical use.
• TSV-Gel Biomaterial with thermosensitive viscosity gel technology, delivering improved handling characteristics during surgical application.
• GTO® Premium biomaterial positioned as the new standard of excellence in the biomaterials market.
• OsteoBiol® Sub-brand of Tecnoss dedicated to dentistry, offering a comprehensive line of xenogenic biomaterials for bone regeneration used by dental surgeons.

Quantifiable outcome

• Over 1,000,000 surgical procedures performed using OsteoBiol biomaterials
• +2 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature5 records

Partnerships

One partnership is on record.

• Bone Biomaterials & Beyond AcademyminorOthersEducational and training partnership with the Bone Biomaterials & Beyond Academy (bbb.academy), providing professional education resources for dental and medical professionals on bone regeneration techniques using OsteoBiol products.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Dentsply Sirona: Largest dental equipment and consumables company globally, with a regenerative/biomaterials segment. Addresses the same dental surgeon customer base with a broader portfolio including implants, prosthetics, and regenerative materials.
• Straumann: Global dental implant leader (Straumann Group) with a regenerative portfolio including botiss products and other biomaterials. Competes with Tecnoss by bundling implants with regenerative materials and leveraging a far larger commercial footprint.
• Smith+Nephew: Global medical device major with significant advanced wound management and biologics portfolios. Overlaps with Tecnoss in wound healing/skin regeneration products (Protexa®, Graftygen® Derma) and competes at the high end of the regenerative wound care market.
• Integra LifeSciences: Public medical technology company with significant regenerative tissue technologies (Integra® Dermal Regeneration Template, collagen-based wound care). Overlaps with Tecnoss's Tecnoss® Protexa® and Graftygen® Derma in the dermal matrix/wound regeneration space.
• Zimmer Biomet: Global orthopedic and dental medical device major with a regenerative medicine portfolio (including biologics for bone and dental regeneration). Overlaps with Tecnoss in dental bone graft substitutes and adjacent orthopedic biomaterials.

Direct peers

• Geistlich Pharma: Swiss-based privately held leader in dental bone regeneration (Bio-Oss®, Bio-Gide®). Most direct comparable to Tecnoss in product category (xenogenic bone graft substitutes and collagen membranes) and customer base (dental surgeons and oral surgeons).
• botiss biomaterials: Germany-based specialist in dental bone and soft tissue regeneration, with comparable product portfolio (bone graft substitutes, membranes, soft tissue grafts) sold through dental distribution networks — a direct competitor in the European dental regeneration segment.

Emerging players

• Collagen Solutions: UK-based developer and manufacturer of collagen-based biomaterials for medical devices and regenerative medicine. Comparable as a specialist supplier of collagen-based medical device materials for tissue repair and regeneration.
• MiMedx: US-based regenerative medicine company focused on placental tissue allografts for wound care and surgical recovery. Comparable as a specialty regenerative biomaterials company pursuing adjacent indications (wound healing, surgical recovery) via biologic materials.
• RTI Surgical: Specialist in sterile biologic implants for orthopedic, sports medicine, and dental surgery, including xenogenic and allograft bone graft products. Comparable in product category (biologic bone substitutes) though larger and more diversified across surgical specialties.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/tecnoss

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tecnoss